Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

Westlake Chemical Partners LP Sees Sharp Rise in Q1 Net Income

Westlake Chemical Partners LP reported first-quarter 2026 net income attributable to the partnership of $14.2 million, up sharply from $4.9 million in the same period a year earlier, but slightly below the $14.5 million posted in the fourth quarter of 2025.

Cash flows from operating activities rose to $110.2 million in the quarter, compared with $45.8 million in the first quarter of 2025, an increase of $64.4 million. Versus the fourth quarter of 2025, operating cash flow fell by $10.2 million from $120.4 million.

MLP distributable cash flow climbed to $17.9 million from $4.7 million a year ago, a gain of $13.2 million. That figure was down $0.9 million from $18.8 million in the prior quarter.

The partnership declared a quarterly distribution of $0.4714 per unit, the 47th consecutive quarterly payout. Trailing 12-month coverage improved to 1.00x at the end of the first quarter from 0.82x at the end of the fourth quarter of 2025.

Production and sales volume were higher than a year earlier, reflecting the absence of the Petro 1 turnaround that affected the prior-year period. The company said lower maintenance capital expenditures also helped boost distributable cash flow. Near the end of the quarter, it said export demand accelerated, lifting third-party ethylene sales prices and supporting cash flow and coverage. As a result of these announcements, the company's shares have moved 2.62% on the market, and are now trading at a price of $23.264. For the full picture, make sure to review Westlake Chemical's 8-K report.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS